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A COS represents an agreed minimum set of outcomes that should be measured and
reported in all trials of a specific condition. The COMET (Core Outcome Measures in Effec-
tiveness Trials) initiative aims to collate and stimulate the development and application of
COS, by including data on relevant studies within a publically available internet-based
resource. In recent years, there has been an interest in increasing the development of COS.
Therefore, this study aimed to provide an update of a previous review, and examine the
quality of development of COS. A further aim was to understand the reasons why individu-
als are searching the COMET database.
Methods
Amulti-faceted search strategy was followed, in order to identify studies that sought to
determine which outcomes/domains to measure in clinical trials of a specific condition.
Additionally, a pop up survey was added to the COMET website, to ascertain why people
were searching the COMET database.
Results
Thirty-two reports relating to 29 studies were eligible for inclusion in the review. There has
been an improvement in the description of the scope of a COS and an increase in the pro-
portion of studies using literature/systematic reviews and the Delphi technique. Clinical
experts continue to be the most common group involved in developing COS, however
patient and public involvement has increased. The pop-up survey revealed the most com-
mon reasons for visiting the COMET website to be thinking about developing a COS and
planning a clinical trial.
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Conclusions
This update demonstrates that recent studies appear to have adopted a more structured
approach towards COS development and public representation has increased. However,
there remains a need for developers to adequately describe details about the scope of
COS, and for greater public engagement. The COMET database appears to be a useful
resource for both COS developers and users of COS.
Introduction
When designing clinical trials, it is important to measure appropriate outcomes, so that the
results can be compared with other trials and will be as useful as possible to decision makers.
At present, many studies which explore the effects of the same intervention on a specific health
condition measure and report different outcomes, making it difficult to compare, contrast or
combine their findings. This causes problems for people trying to use healthcare research.
Inconsistency in outcome measurement and outcome reporting bias have led to avoidable
waste in the production and reporting of research [1,2]. However, these issues could be reduced
through the development and application of core outcome sets (COS). A COS represents an
agreed minimum set of outcomes that should be measured and reported in all trials of a specific
condition [3]. The existence of a COS allows the results of trials to be brought together as
appropriate and ensures that all trials provide usable evidence. COS are not intended to restrict
the number of outcomes in a particular trial, rather, the intention is that the outcomes in the
COS will always be collected and reported, and it is fully expected that researchers will continue
to explore additional outcomes [3].
The COMET (Core Outcome Measures in Effectiveness Trials) initiative aims to collate and
stimulate the development, application and promotion of COS, by including data on relevant
individual studies within a publically available internet-based resource. The COMET database
is a unique inventory that includes published accounts of COS development, as well as planned
and ongoing work. Initially, the database included studies that had been identified by ad hoc
means and a systematic review which addressed outcome selection in clinical trials in children
[4]. In order to bring the database content up-to-date and be comprehensive, a systematic
approach was needed to identify relevant material. Gargon and colleagues [5] conducted a sys-
tematic review in 2013, the first comprehensive search for COS in health research, and identi-
fied 198 studies that determined which outcomes or domains should be measured in all clinical
trials for a specific health condition. The review revealed wide variation in the methods used to
develop COS, and highlighted the need for methodological guidance, including how to engage
key stakeholder groups, particularly members of the public, in the development and implemen-
tation of COS. When using the term ‘public’ through this report we include patients, carers,
health and social care service users and people from organisations who represent these groups
[6]. The involvement of the public in the development of COS is particularly relevant for com-
parative effectiveness research where long term patient centred outcomes are often the impor-
tant endpoints.
Awareness of the need for COS and knowledge of the COMET Initiative has continued to
grow, reflected in website and database usage figures [7]. More than 16,500 visits were made to
the website in 2014 (36% increase over 2013) and 9780 new visitors (43% increase). By Decem-
ber 2014, a total of 6588 searches of the COMET database had been completed; however no
information had been collected about the reasons for searching the database.
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Aims
To update the original systematic review [5], in order to identify any further studies where a
COS has been developed, and to describe the methodological techniques used in these studies.
In addition, to understand the reasons why individuals are searching the COMET database.
Methods
Systematic review update
The methods used in this updated review followed the same approach used in the original
review [5].
Study selection. Inclusion and exclusion criteria. As described in detail previously [5].
Broadly speaking, studies were eligible for inclusion if they had applied methodology for deter-
mining which outcome domains or outcomes should be measured, or are important to mea-
sure, in clinical trials or other forms of health research.
Types of participants and interventions. As previously [5], studies were categorised as
eligible if they related to participants of any age, with any health condition, in any setting, and
assessed the effect of any or all interventions for that condition.
Identification of relevant studies. In January 2015, we searched MEDLINE via Ovid and
SCOPUS (including EMBASE) without language restrictions. The search identified studies that
had been published from January 2013 onwards (MEDLINE) and August 2013 onwards (SCO-
PUS). The multifaceted search strategy developed in the original review using a combination of
text words and index terms [8] was used in the current review, with adaptations appropriate
for each database.
Selecting studies for inclusion in the review. Records from each database were combined
and duplicates were removed. Titles and abstracts were read to assess eligibility of studies for
inclusion in the review (stage 1). Full texts of potentially relevant articles were obtained to assess
for inclusion (stage 2). Two of three reviewers (SG, JW and BG) independently checked the title
and abstract of each citation. One reviewer (SG) assessed the title and abstract of all citations. A
second reviewer (JW) assessed the title and abstract of the first half of the citations and a third
reviewer (BG) assessed the title and abstract of the second half of the citations. Citations were
retained for further checking if agreement could not be reached. One reviewer (SG) assessed each
full paper for inclusion in the review and another reviewer (BG) assessed half of the full papers.
Reasons for exclusion at this stage were documented for articles judged to be ineligible.
Checking for agreement between reviewers. During each stage of the review process,
agreement between reviewers was assessed. Prior to independently assessing records, the three
reviewers (SG, JW and BG) independently checked batches of abstracts and full papers for
agreement.
Checking for correct exclusion. Of the records that had been excluded on the basis of the
title and abstract, full text papers were obtained for a 1% sample and a fourth reviewer (EG)
assessed correct exclusion. If any studies were identified as being incorrectly excluded, further
checking was performed within the other excluded records. Of the records that had been
excluded after reading their full text papers, 5% were assessed for correct exclusion at that
stage.
Data extraction. As described in detail previously [5], data were extracted in relation to
the study aims, health area, target population, methods of COS development and stakeholder
groups involved.
Data analysis and presentation of results. As described previously [5], the results are pre-
sented descriptively.
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Pop-up survey
During May-June 2015, a pop up survey consisting of one question was added to the COMET
website search page, with the intention of finding out why people were searching in the
COMET database. At the beginning of each search, the survey would appear, to ask people to
select a response as to their reason for searching in the COMET database. The survey was
designed so that it was just one question with a set of multiple-choice answers, which was fully
contained within the pop-window. This meant that people could answer the question and close
the window with a single click. People were asked only once to do this although they could
have run a number of searches.
Results
Description of studies
Following the removal of duplicates, 4980 citations were identified in the initial database
search. A total of 4551 records were excluded during the title and abstract stage, and a further
400 were excluded following the assessment of full text papers (Fig 1). S1 Table provides a sum-
mary of the reasons for exclusion of the full text papers. Twenty-nine citations met the inclu-
sion criteria. In addition to the database search, three additional citations were identified as
being eligible for inclusion in the review following reference checking. In total, 32 reports relat-
ing to 29 new studies were included (S2 Table).
Included studies
Year of publication. The figure displaying the year of first publication of each COS that
was included in the original review has been updated to include the 29 new studies identified in
this updated review (Fig 2). The figure confirms that there has been a general increase in the
number of COS over the years, and shows that there has been a consistently higher number of
COS published annually in recent years than in most years before 2010. Of the 29 studies iden-
tified in this update, 28 studies were published between 2013 and 2014, and one study was pub-
lished in 2010. This study was identified in the searches for the original review [5], but the lack
of information on the COS in the title and abstract meant that it was excluded in the initial
stages of that review. This study was identified in the updated review, through the checking of
references in the included studies, thus highlighting the value of checking reference lists for
locating studies in systematic reviews [9].
Scope of core outcome sets. Fig 3 shows the number of COS developed according to dis-
ease category. The classification of 227 published COS studies are presented in S3 Table. The
scope of published COS studies is summarised in Table 1 and includes both the 198 COS
included in the original review and the 29 new COS that have been added by this updated
review. This includes study aims, setting for intended use, population characteristics and inter-
vention characteristics.
There has been an improvement in the description of the scope of a COS. In the original
review, only 25% (49/198) of studies were found to clearly define the population characteristics,
as compared to 55% (n = 16/29) of studies in the updated review. The majority, 58% (n = 115/
198), of studies in the original review neglected to report intervention characteristics, compared
to 17% (n = 5/29) in the update.
Methods used to select outcomes. COS have been developed using a variety of methods
[5]. The inclusion of a literature/systematic review to inform the development has increased
from 33% (n = 66/198) of studies in the original review to 72% (n = 21/29) of studies in the
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updated review. The use of the Delphi technique for assessing and developing consensus has
risen from 15% (n = 29/198) in the original review to 31% (n = 9/29) in the updated review.
People involved in selecting outcomes. The stakeholder groups regarded as key to devel-
oping a COS will vary between clinical areas. Clinical experts continue to be involved in almost
all studies (see S4 Table), but there has been a trend towards greater involvement of patient
and public representatives, increasing from 18% (31/174) in the original review, to 59% (13/22)
in this updated review. Table 2 describes the degree of patient representation reported in COS
studies included in this updated review.
Pop-up survey
During the four-week period of the survey, 396 different people searched the database. The sur-
vey achieved a 52% (206/396) response rate. Table 3 shows the frequency of the reasons
selected. The most common were ‘I am thinking about developing a core outcome set’ and ‘I
am planning a clinical trial’.
Fig 1. Identification of studies.
doi:10.1371/journal.pone.0146444.g001
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Discussion
As in the original review, studies identified in this update covered various areas of health, with
cancer and rheumatology being the most common. In addition to identifying the areas where
COS are continuing to be developed, the review identified that COS had been developed for the
first time in the areas of rehabilitation and eyes & vision. Regular review updates will allow us
to identify the areas where there is an ongoing absence of COS, which may highlight future
opportunities for COS developers.
It is apparent that many studies still do not report important characteristics pertaining to
the scope of the COS. The development and implementation of a reporting guideline, may
facilitate improved reporting of COS, a project currently underway [10].
A variety of methods continue to be used to develop COS. However, there has been an
increase in the proportion of studies using literature/systematic reviews and the Delphi tech-
nique. As in the original review, the updated review found clinical experts to be the most com-
mon group involved in developing COS. However, the proportion of studies that reported
patient and public involvement in the process has increased. Since the systematic search was
completed in January 2015, we are aware of a further six COS studies that have been published,
and of these six studies, 100% have included patient and public representatives. In addition,
patient and public representatives are also involved in 89% (64/72) of the planned and ongoing
studies registered in the COMET database. It is important that clinical trials include outcomes
that are considered to be important to patients and other users of health and social care. It
appears that the issue of patient and public involvement is no longer about whether to involve,
but rather how. In response to this need, COMET has set up the PoPPIE (People and Patient
Fig 2. Year of first publication of each COS study (n = 227).
doi:10.1371/journal.pone.0146444.g002
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Participation, Involvement and Engagement) Working Group to develop resources in this
area. As an example, plain language summaries are being developed in partnership with
patients, http://www.comet-initiative.org/resources/PlainLanguageSummary, and a research
agenda around methods for patient engagement has been set.
Implications
The studies identified in this updated review have been added to the COMET database; a freely
accessible, publically available, searchable online resource that shows what work has been done
in relation to outcomes to measure in effectiveness trials. This update has ensured that the
database stores the most current research, and provides readily available information about
existing COS, which will assist researchers, practitioners and other stakeholders, including the
public, when designing new clinical trials, systematic reviews and clinical guidelines. Moreover,
it will also help to avoid unnecessary duplication of efforts in COS development.
The results of the pop up survey demonstrate that people thinking about developing a COS
are checking the COMET database to see whether a COS exists in their area of interest to avoid
such duplication, hence emphasising the importance of keeping the database current. The pop-
up survey also shows that the COMET database is being used for a variety of reasons by people
besides COS developers, including clinical trialists, systematic reviewers, auditors, COS fund-
ers, and people who have been asked to participate in the development of COS. Interestingly,
nearly one sixth of respondents were searching for reasons not anticipated, and further
research is needed to understand those. Although 48% of visitors to the website did not
Fig 3. Number of COS developed in each disease category (n = 227).
doi:10.1371/journal.pone.0146444.g003
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Table 1. The scope of included studies (n = 227).
Original review n (%) Updated review n (%) Combined n (%)
Study aims
Speciﬁcally considered outcome selection and measurement 97 (49) 22 (76) 119 (52%)
Considered outcomes while addressing wider clinical trial design issues 101 (51) 7 (24) 108 (48%)
Intended use of recommendations
Clinical trials 141 (71) 19 (66) 160 (71)
Clinical research 27 (14) 4 (14) 31 (14)
Clinical research and practice 11 (6) 4 (14) 15 (7)
Clinical trials and clinical practice 10 (5) 0 (0) 10 (4)
Clinical trials and regulatory purposes 3 (2) 0 (0) 3 (1)
Trials and observational studies 3 (2) 0 (0) 3 (1)
Clinical trial extension studies 1 (4) 1 (<1)
Clinical trials, research and clinical record keeping 1 (4) 1 (<1)
Observational studies 1 (<1) 0 (0) 1 (<1)
Trials and case series 1 (<1) 0 (0) 1 (<1)
Clinical research, clinical practice and regulatory purpose 1 (<1) 0 (0) 1 (<1)
Population characteristics
Adults 10 (5) 11 (38) 21 (9)
Children 23 (12) 2 (7) 25 (11)
Adults and children 13 (7) 1 (4) 14 (6)
Older adults 3 (2) 1 (4) 4 (2)
Adults and neonates 0 (0) 1 (4) 1 (<1)
Not speciﬁed 149 (75) 13 (45) 162 (71)
Intervention characteristics
All intervention types 7 (4) 9 (31) 16 (7)
Drug treatments 40 (20) 4 (14) 44 (19)
Surgery 13 (7) 4 (14) 17 (8)
Surgery only 13 2
Surgery and compression therapy 0 1
Surgery and injection 0 1
Vaccine 2 (1) 0 (0) 2 (1)
Rehabilitation 1 (1) 1 (4) 2 (1)
Exercise 1 (1) 1 (4) 2 (1)
Exercise (physical activity) 1 0
Exercise (yoga) 0 1
Procedure* 5 (3) 0 (0) 5 (2)
Device** 3 (2) 0 (0) 3 (1)
Other*** 11 (6) 5 (17) 16 (7)
(Continued)
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respond to the survey, closing down the pop-up box immediately, this may reflect a typical
response rate for such surveys.
Limitations
There are a number of limitations of this review that should be noted. First, although two well-
established, large bibliographic databases were searched to identify studies meeting the inclu-
sion criteria, we may have missed some relevant studies within these databases, either because
the reports of these studies are not indexed in these databases or because the information in the
indexed record is insufficient to show that the report is eligible. It would be beneficial for bib-
liographic databases to introduce an indexing term to facilitate easier identification of COS. As
shown by both our original review [8] and this update, the identification of COS is a complex
task and we will keep the search strategy under review and refine it as necessary to minimise
the possibility of missing eligible studies in the future.
A second limitation of the review is that the lack of an assessment tool means that there has
been no formal quality assessment of the included studies. Determining the quality of a COS is
not straightforward. A high quality COS would be one that leads to improved health outcomes
but this would be difficult to measure. A tool is needed to assess how the COS developers
Table 1. (Continued)
Original review n (%) Updated review n (%) Combined n (%)
Not speciﬁed 115 (58) 5 (17) 120 (53)
*Procedure descriptions–
Procedure—Uterine artery embolization.
Procedure—Aortic valve stenosis (AS)—transcatheter aortic valve implantation.
Procedure—Aortic valve stenosis (AS).
Procedure—pulp treatments of primary teeth.
Procedure—drug-eluting coronary stents (DES).
**Device descriptions–
Device–Compression (n = 2).




Neuro-protective therapy (aka Neuroprotection).
Non-surgical treatment (no other detail given).
Operative and non-operative management.
Oral care products.
Ascorbic acid.
Fall injury prevention interventions.
Behavioural therapies or other kinds of nonpharmacologic therapies.
Psychological & behavioural: Psychosocial.
Maternity care.




Constraint-induced movement therapy (CIMT).
doi:10.1371/journal.pone.0146444.t001
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minimised biases which would otherwise undermine the ability of the COS to have a positive
impact on patient care and outcomes.
Conclusion
We have provided an updated review of studies that have addressed the development of COS
for measurement and reporting in clinical trials. The updated review has demonstrated that
Table 2. Public involvement detail where reported (n = 6).
Methods used Total number of participants Number of public participants % Public participants
1 Meeting and teleconferences (mixed) 6 1 17%
2 Nominal Group Technique (mixed) 25 3 12%
3 Meeting (mixed) 12 1 8%
4 Focus groups (patient only) 45 45
Delphi (clinician only) Round 1: 249 Round 1: 249
Round 2: 247 Round 2: 247
Round 3: 247 Round 3: 247
Nominal Group Technique (mixed) 28 5 18%
5* Delphi (patient only) Round 1: 169 Round 1: 169
Round 2: 152 Round 2: 152
Round 3: 147 Round 3: 147
6 Delphi (patient only) Round 1: 71 Round 1: 71
Round 2: 67 Round 2: 67
Round 3: 62 Round 3: 62
Delphi (clinician only) Round 1: 39 Round 1: 39
Round 2: 35 Round 2: 35
Round 3: 33 Round 2: 33
Round 2: 35 Round 2: 35
Round 3: 33 Round 2: 33
* Patient core set
doi:10.1371/journal.pone.0146444.t002
Table 3. Results from pop-up survey.
Reason N
I am thinking about developing a core outcome set 49
We are considering funding a core outcome set 3
I am reviewing a funding application for the development of a core outcome set 0
I have been asked to take part in a core outcome set study 2
I am a person with a condition 0
I am planning a systematic review of clinical trials 19
I am planning a clinical trial 33
I am reviewing a funding application for a trial 4
We are considering funding a clinical trial 2
I am involved in auditing a condition 6
As part of a general educational activity 29
General interest 27
None of the above 32
Did not respond 190
Total 396
doi:10.1371/journal.pone.0146444.t003
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COS are continuing to be developed across a range of health areas. Recent studies appear to
have adopted (or, at least, reported) a more structured approach towards COS development,
and public representation has increased. However, although general reporting quality has
increased, there remains a need for developers to adequately describe details about the scope of
COS, and for greater public engagement. The COMET database is likely to be a useful resource
for both COS developers and users of COS including clinical trialists and systematic reviewers.
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